Filter Results:
(5,333)
Show Results For
- All HBS Web
(5,333)
- People (3)
- News (1,387)
- Research (3,339)
- Events (46)
- Multimedia (58)
- Faculty Publications (2,337)
Show Results For
- All HBS Web
(5,333)
- People (3)
- News (1,387)
- Research (3,339)
- Events (46)
- Multimedia (58)
- Faculty Publications (2,337)
- 01 Jun 2003
- News
Up Against The Firewall
to law enforcement? How much disclosure is legally required, and how much is appropriate ethically? How will disclosure affect the company’s stock price and prospects for... View Details
- 01 Apr 2000
- News
Q & A: A Conversation with IRS Chief Charles Rossotti
technically be within the law but has no practical business purpose. It's just sleight of hand to reduce taxes without a legitimate reason. Typically, it's the bigger companies and multinationals that engage... View Details
Keywords: Garry Emmons
- 02 Jan 2014
- Blog Post
Preparing for a career in investment banking
Time has flown! I am already feeling nostalgic about my first term at HBS and how I will miss having section (f)un until almost February. The past two months have been hectic. Recruiting kicked off in mid-October View Details
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food View Details
- 01 Jul 2019
- Research & Ideas
The Airbnb Lesson for Startups? Success Takes More Than Technology
it wasn’t hard for Airbnb to establish a toehold fast. Without the overhead of real estate and hotel staff, Airbnb has quickly expanded into related services, making it tougher for incumbents to compete, says Teixeira. After lobbying... View Details
- July 2008 (Revised September 2008)
- Case
Recent Developments in the Ranbaxy Case
By: Robert C. Pozen
This brief case describes settlements Indian drug maker Ranbaxy has made with Pfizer and AstraZeneca, as well as Daiichi Kangyo's purchase of a majority shareholding in Ranbaxy in 2008. View Details
Keywords: Mergers and Acquisitions; Patents; Lawsuits and Litigation; Ownership Stake; Pharmaceutical Industry; India
Pozen, Robert C. "Recent Developments in the Ranbaxy Case." Harvard Business School Case 609-010, July 2008. (Revised September 2008.)
- 03 Aug 2010
- First Look
First Look: August 3
PublicationsLords of the Harvest: Symbolic Signaling and Regulatory Approval of Genetically Modified Organisms Authors:Shon R. Hiatt and Sangchan Park Publication:Best Paper Proceedings of the Academy of... View Details
Keywords: Martha Lagace
- 29 May 2012
- First Look
First Look: May 29
2012) Abstract Controversy surrounds occupational health and safety regulators, with some observers claiming that workplace regulations damage firms' competitiveness and... View Details
Keywords: Sean Silverthorne
- December 2010
- Article
The Case for Professional Boards
By: Robert C. Pozen
When the world's largest financial institutions had to be rescued from insolvency in 2008, many experts laid the blame at the feet of corporate boards. But insufficient board oversight is a problem that had supposedly been solved in 2002. As the United States... View Details
Keywords: Financial Institutions; Insolvency and Bankruptcy; Governing and Advisory Boards; Failure; Accounting Audits; Quality; Behavior; Legal Liability; Experience and Expertise; Corporate Governance; Governance Controls; Performance Effectiveness; United States
Pozen, Robert C. "The Case for Professional Boards." Harvard Business Review 88, no. 12 (December 2010).
- 21 Sep 2010
- First Look
First Look: September 21, 2010
economic downturn. The case is complemented by a video (HBS No. 810-704) with co-founder commentary and extensive live footage of Blue Man performances and the Blue School. Purchase this... View Details
Keywords: Sean Silverthorne
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical... View Details
Keywords: Martha Lagace
- 06 Jan 2012
- Op-Ed
Where Green Corporate Ratings Fail
News Corporation—a multinational media conglomerate that includes BSKYB, Dow Jones, Fox News, 20th Century Fox and Star, among other units—announced earlier this year that it has become climate neutral, meaning that its operations have no net impact on global climate... View Details
- 17 Nov 2015
- News
Carbon Neutral
Eacho, left, and Minnick (Getty Images) Congress is at a standstill over carbon. One side wants to regulate emissions as a pollutant; the other fears that any move to regulate... View Details
Keywords: Michael Blanding
- 16 Jul 2024
- Blog Post
Advancing Health Equity: Social Enterprise Summer Fellow Simona Stancov (MBA 2025)
allowed me to appreciate that organizations’ choices across these business domains do not exist in a vacuum. Health facilities are shaped by the systems to which they belong. These systems, in turn, are regulated View Details
- 23 Nov 1999
- Research & Ideas
Bringing the Environment Down to Earth
groups are the company's adversaries. At times, that view is justified; some regulators and advocates are indeed hostile to business. But government and nonprofit organizations... View Details
Keywords: by Forest Reinhardt
- 08 May 2012
- First Look
First Look: May 8
weakening its capacity to achieve espoused goals and eroding public trust. In the private sector, institutional corruption typically entails gaming society's laws and... View Details
Keywords: Carmen Nobel
- 01 May 2015
- Blog Post
How Being an HBS Partner Changed My Life
that I was willing to hear and ready to answer the single question HBS has asked its community for generations: “what do you want your life to be?” And as a response, I recently decided to leave my View Details
- 22 Dec 2009
- First Look
First Look: Dec. 22
http://cb.hbsp.harvard.edu/cb/product/810071-PDF-ENG Memo from Counsel: Antitrust Law and Customer Allocation Lynn S. Paine and Lara AdamsonsHarvard Business School Note... View Details
Keywords: Martha Lagace